OBJECTIVE: To determine the nature and extent to which asthma characteristics and management differ between allergy and pulmonary subspecialists. PATIENTS AND METHODS: We used baseline data from 3342 adults enrolled in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study, a multicenter, observational cohort recruited from subspecialty practices across the United States. Information on physician subspecialty, asthma history, allergic status, lung function, medication use, and recent health care use was collected from January 1, 2001, through April 30, 2004, via study coordinator-administered interviews and self-administered validated questionnaires. RESULTS: In the TENOR study, 2407 patients (72%) were treated by allergists and 935 (28%) by pulmonologists. Patients treated by pulmonologists were more likely to be black, be less educated, and have lower incomes than those treated by allergists. Pulmonary patients had more severe asthma as indicated by physician assessment, Global Initiative for Asthma classification, lung function, and number of asthma control problems. Regular use of a short-acting beta-agonist and systemic corticosteroid use were also higher among pulmonologist-treated patients than allergist-treated patients, consistent with greater asthma severity. Although evidence of allergic disease was prevalent in both types of patients, those treated by an allergist were more likely to receive skin testing or immunotherapy. In multivariate analyses adjusted for demographic differences, patients treated by pulmonologists were more likely to report health care use for asthma in the past 3 months. CONCLUSION: In general, asthma patients treated by pulmonologists have lower socioeconomic status, have more severe disease, require more medication, and report greater health care use than those treated by allergists.
OBJECTIVE: To determine the nature and extent to which asthma characteristics and management differ between allergy and pulmonary subspecialists. PATIENTS AND METHODS: We used baseline data from 3342 adults enrolled in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study, a multicenter, observational cohort recruited from subspecialty practices across the United States. Information on physician subspecialty, asthma history, allergic status, lung function, medication use, and recent health care use was collected from January 1, 2001, through April 30, 2004, via study coordinator-administered interviews and self-administered validated questionnaires. RESULTS: In the TENOR study, 2407 patients (72%) were treated by allergists and 935 (28%) by pulmonologists. Patients treated by pulmonologists were more likely to be black, be less educated, and have lower incomes than those treated by allergists. Pulmonary patients had more severe asthma as indicated by physician assessment, Global Initiative for Asthma classification, lung function, and number of asthma control problems. Regular use of a short-acting beta-agonist and systemic corticosteroid use were also higher among pulmonologist-treated patients than allergist-treated patients, consistent with greater asthma severity. Although evidence of allergic disease was prevalent in both types of patients, those treated by an allergist were more likely to receive skin testing or immunotherapy. In multivariate analyses adjusted for demographic differences, patients treated by pulmonologists were more likely to report health care use for asthma in the past 3 months. CONCLUSION: In general, asthma patients treated by pulmonologists have lower socioeconomic status, have more severe disease, require more medication, and report greater health care use than those treated by allergists.
Authors: William M Vollmer; Leona E Markson; Elizabeth O'Connor; E Ann Frazier; Marc Berger; A Sonia Buist Journal: Am J Respir Crit Care Med Date: 2002-01-15 Impact factor: 21.405
Authors: W M Vollmer; L E Markson; E O'Connor; L L Sanocki; L Fitterman; M Berger; A S Buist Journal: Am J Respir Crit Care Med Date: 1999-11 Impact factor: 21.405
Authors: M E Vilar; B M Reddy; B A Silverman; C W Bassett; Y A Rao; L T Chiaramonte; A T Schneider Journal: Ann Allergy Asthma Immunol Date: 2000-03 Impact factor: 6.347
Authors: June H Lee; Tmirah Haselkorn; Larry Borish; Lawrence Rasouliyan; Bradley E Chipps; Sally E Wenzel Journal: Chest Date: 2007-12 Impact factor: 9.410
Authors: Paul D Blanc; Laura Trupin; Gillian Earnest; Melanie San Pedro; Patricia P Katz; Edward H Yelin; Mark D Eisner Journal: Am J Med Date: 2003-05 Impact factor: 4.965
Authors: Lewis J Kanter; Charles J Siegel; Claire F Snyder; Elise M Pelletier; Deborah A Buchner; Thomas F Goss Journal: Ann Allergy Asthma Immunol Date: 2002-08 Impact factor: 6.347
Authors: Michelle M Cloutier; Lara J Akinbami; Paivi M Salo; Michael Schatz; Tregony Simoneau; Jesse C Wilkerson; Gregory Diette; Kurtis S Elward; Anne Fuhlbrigge; Jacek M Mazurek; Lydia Feinstein; Sonja Williams; Darryl C Zeldin Journal: J Allergy Clin Immunol Pract Date: 2020-04-25
Authors: Bradley E Chipps; Robert S Zeiger; Larry Borish; Sally E Wenzel; Ashley Yegin; Mary Lou Hayden; Dave P Miller; Eugene R Bleecker; F Estelle R Simons; Stanley J Szefler; Scott T Weiss; Tmirah Haselkorn Journal: J Allergy Clin Immunol Date: 2012-06-12 Impact factor: 10.793
Authors: Sang Heon Kim; Ji Yong Moon; Jae Hyun Lee; Ga Young Ban; Sujeong Kim; Mi Ae Kim; Joo Hee Kim; Min Hye Kim; Chan Sun Park; So Young Park; Hyouk Soo Kwon; Jae Woo Kwon; Jae Woo Jung; Hye Ryun Kang; Jong Sook Park; Tae Bum Kim; Heung Woo Park; You Sook Cho; Kwang Ha Yoo; Yeon Mok Oh; Byung Jae Lee; An Soo Jang; Sang Heon Cho; Hae Sim Park; Choon Sik Park; Ho Joo Yoon Journal: Allergy Asthma Immunol Res Date: 2018-05 Impact factor: 5.764